Investor Relations

VIDEO SPOTLIGHT


"Perimeter Medical Imaging CEO Adrian Mendes joined Steve Darling from Proactive to discuss the strategic developments and innovations the company"

The opinions expressed within the content are solely the author's and do not reflect the opinions and beliefs of the website or its affiliates.
* The S-Series Optical Coherence Tomography (OCT) System is indicated for use as an imaging tool in the evaluation of excised human tissue microstructure, by providing two-dimensional, cross-sectional, real-time depth visualization, with image review manipulation software for identifying and annotating regions of interest.

Company Overview

About Perimeter Medical Imaging AI, Inc.

Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation, artificial intelligence technology that is currently under clinical development. The company’s ticker symbol “PINK” is a reference to the pink ribbons used during Breast Cancer Awareness Month.

Latest Financial Results

Q2 2023

Quarter Ended Jun 30, 2023

Investor Contact Information

Company

Perimeter Medical Imaging
8585 N. Stemmons Fwy.
Suite 106N
Dallas, TX, TX 75247
Toll-Free: (888) 988-7465 (PINK)
T: (214) 845-5154
F: (972) 587-7795
investors@perimetermed.com

Transfer Agent

Computershare
P.O. Box 43078
Providence, RI 02940
https://www.computershare.com

Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.